Some hematopoietic stem cells are more equal than others by Hock, Hanno
1127
Minireview
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 207 No. 6  1127-1130
www.jem.org/cgi/doi/10.1084/jem.20100950
In  1996,  a  group  led  by  Hiromitsu 
Nakauchi  in  Tokyo  was  the  first  to 
develop a method that permitted suf-
ficient  enrichment  of  murine  HSCs 
to allow individual stem cells to be 
transplanted at high frequency and to 
formally  demonstrate  that  single  cells 
harbor the potential to replicate them-
selves  (self-renewal)  and  give  rise  to 
the  entire  repertoire  of  differentiated 
blood  cell  types  (multilineage  poten-
tial) for long periods of time (Osawa 
et al., 1996). Since then, studies from 
several  groups  investigating  hemato-
poiesis using single-cell transplantation 
established  that  individual  HSCs  dis-
play heterogenous stable “characters,” 
in regard to the balance of lineages they 
produce,  their  self-renewal  capacity, 
and their engraftment kinetics (Fig. 1; 
Muller-Sieburg et al., 2002, 2004; Ema 
et al., 2005; Dykstra et al., 2006). In this 
issue, another group led by Nakauchi 
(Morita et al., 2010) set out to prospec-
tively isolate subtypes of HSCs.
The  team  initially  screened  >100 
surface markers to identify candidates 
showing differential expression on al-
ready  highly  purified  HSCs  (CD34
 
c-Kit
Sca1
Lineage marker
). They 
subsequently  tested  those  15  markers 
that  did  show  differential  expression 
in transplantation assays. CD150 (also 
known as signaling lympocyte activa-
tion family member 1 [SlamF1]), which 
was  initially  identified  as  a  stem  cell 
marker by Kiel et al. (2005), emerged 
as perhaps the most interesting candi-
date (Morita et al., 2010). Single-cell 
transplantation of HSCs distinguished 
by their level of CD150 surface expres-
sion yielded important insights that will 
be discussed in the context of other re-
cently published findings.
Abundant CD150 predicts robust HSC 
self-renewal
Bone marrow cells from all 13 mice 
transplanted  with  single  CD150
high 
HSCs gave rise to hematopoiesis after 
secondary transplantation (Morita et al., 
2010). In contrast, only a minority of 
single  CD150
med  or  CD150
neg  HSCs 
gave rise to significant hematopoiesis in 
secondary  recipients  (Morita  et  al., 
2010).  These  findings  dovetail  with 
data  demonstrating  (with  an  entirely 
different  HSC  enrichment  strategy) 
that  CD150  expression  predicts  suc-
cessful  repopulation  of  secondary  re-
cipients (Kent et al., 2009). Together, 
these  data  put  earlier  controversies 
(Akala et al., 2008; Kiel et al., 2008; 
Weksberg et al., 2008) about whether 
CD150
neg HSCs exist into perspective 
and suggest that the answer is to some 
degree arbitrary. A proportion of HSCs 
lacking CD150 meet the conventional 
criteria for HSC activity in primary 
recipients, but these cells largely lack 
durable self-renewal in secondary trans-
plant assays. High expression of CD150 
marks HSCs with the most potent self-
renewal capacity.
CD150 levels predict myeloid versus 
lymphoid reconstitution potential
Morita et al. (2010) further demonstrate 
that single CD150
high HSCs display ro-
bust  myeloid  reconstitution  potential 
upon transplantation, whereas CD150
neg 
HSCs mediate only faint myeloid, but 
superior lymphoid, reconstitution; these 
patterns  appeared  stable  in  secondary 
transplantations.  Recently,  three  other 
groups  independently  reported  similar 
findings,  even  though  the  enrichment 
strategies for HSCs were quite dissimilar 
except for the use of CD150 (Kent et al., 
2009; Beerman et al., 2010; Challen 
et  al.,  2010).  Specifically,  Kent  et  al. 
(2009) examined lymphoid versus my-
eloid  reconstitution  patterns  associated 
with the absence or presence of CD150 
on HSCs (defined as CD45
+EPCR
+ 
CD48
; Kiel et al., 2005; Balazs et al., 
2006) and report a strong predominance 
of myeloid or lymphoid reconstitution 
after  transplantation  of  CD150
+  or 
CD150
 cells, respectively. Challen et al. 
(2010)  demonstrated  that  myeloid  and 
lymphoid-biased HSCs can be purified 
based on Hoechst dye efflux in combina-
tion with the absence of lineage markers 
and the presence of Sca-1 and c-Kit; fur-
ther separation of these HSCs based 
on  CD150  expression  enhanced  dis-
crimination of the lineage bias. Finally, 
Beerman et al. (2010) used an HSC iso-
lation strategy similar to that used by 
Hematopoietic stem cells (HSCs) save lives in routine clinical practice every 
day, as they are the key element in transplantation-based therapies for 
hematologic malignancies. The success of clinical stem cell transplantation 
critically relies on the ability of stem cells to reconstitute the hematopoietic 
system for many decades after the administration of the powerful chemo-
therapy and/or irradiation that is required to eradicate malignant cells, but 
also irreversibly ablates patients’ own blood forming capacity. Surprisingly, 
despite enormous efforts and continuous progress in the field, our under-
standing of the basic biology of HSCs is still rather incomplete. Several recent 
studies substantially refine our understanding of the cells at the very top of 
the hematopoietic hierarchy, and suggest that we may need to revise the 
criteria we typically use to identify and define HSCs.
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lineage-biased HSC subtypes respond 
differently to transforming growth fac-
tor-1 (Challen et al., 2010). Decipher-
ing  the  regulation  of  different  HSC 
populations and investigating their po-
tential cross talk is an important task for 
the future.
CD150
neg HSCs: a step toward 
lymphoid-primed multipotent 
progenitors
CD150
neg HSCs harbor an impressive 
capacity  to  reconstitute  the  lymphoid 
system (Kent et al., 2009; Beerman et al., 
2010; Challen et al., 2010; Morita et al., 
2010). This may be interpreted as a first 
step  toward  lymphoid  differentiation. 
However, their partially preserved self-
renewal and the absence of expression 
of  Flt-3  clearly  distinguish  CD150
neg 
HSCs from the first known major stage 
of  lymphoid  differentiation,  the  lym-
phoid-primed  multipotent  progenitor 
(LMPP; Adolfsson et al., 2005). Sup-
porting a close developmental relation-
ship  between  CD150
neg  HSCs  and 
LMPPs,  CD150
low  HSCs  give  rise  to 
LMPPs  after  transplantation  much 
more efficiently than CD150
high HSCs 
(Beerman et al., 2010). In addition, 
CD150
neg  HSCs  harbor  diminished 
erythroid-megakaryocytic  potential  in 
vitro (Morita et al., 2010). This is in-
triguing  because  loss  of  erythroid-
megakaryocytic  potential,  even  if 
controversial  (Forsberg  et  al.,  2006), 
was  described  as  a  hallmark  trait  of 
LMPPs  (Adolfsson  et  al.,  2005;  Luc   
et al., 2007). Thus, it appears that self-
renewal is  not  always  entirely  extin-
guished during the initial steps toward 
lineage differentiation.
“Latent” CD150
high HSCs
The analysis of reconstitution patterns 
performed by Morita et al. (2010) sug-
gests that the CD150
high HSC popula-
tion is still heterogeneous. In the future, 
new markers may resolve this popula-
tion even further. They report two pat-
terns of engraftment of CD150
high HSCs 
that  challenge  conventional  expecta-
tions. First, some stem cells appear to 
exclusively  give  rise  to  myeloid  cells 
and, nevertheless, are capable of repop-
ulating secondary hosts. Second, up to 
different populations might be able to 
convert into each other, or they may 
derive  from  a  parental  stem  cell  that 
may or may not persist into adulthood 
(Challen et al., 2010). Both Morita et al. 
(2010) and Beerman et al. (2010) dem-
onstrate that CD150
high HSCs can give 
rise to CD150
high HSCs (themselves), as 
well as to CD150
low and CD150
neg HSCs 
after transplantation, but that CD150
low 
and CD150
neg HSCs fail to give rise to 
CD150
high  HSCs.  Thus,  CD150
high 
HSCs represent the top of the hierar-
chy.  Yet,  it  is  unclear  at  this  point 
whether CD150
high HSCs continuously 
replenish  CD150
low  and  CD150
neg 
HSCs during the steady state in adult 
bone  marrow.  Beerman  et  al.  (2010) 
show that CD150
low HSCs cycle very 
infrequently. Consistent with this, using 
histone 2B-GFP label retention Foudi 
et al. (2009) demonstrated that CD150
neg 
HSCs (Lineage marker
c-Kit
+Sca-1
+ 
CD48
) turn over almost as slowly as 
CD150
+  HSCs.  Hence,  it  is  possible 
that this population can be maintained 
for long periods of time, even with lim-
ited self-renewal capacity. During nor-
mal aging, CD150
high HSC populations 
expand while CD150
low HSC popula-
tions diminish, suggesting that they are 
differentially regulated (Beerman et al., 
2010).  More  directly,  this  notion  is   
supported  by  the  demonstration  that 
Nakauchi’s group and detected the same 
lineage bias associated with CD150 ex-
pression. Interestingly, this study revealed 
that the proportion of CD150
high HSCs 
strikingly increases with aging, whereas 
the proportion of CD150
neg or CD150
low 
HSCs  strikingly  diminishes  with  aging, 
suggesting that the well documented   
aging-related compromise of lymphopoi-
esis (Sudo et al., 2000; Rossi et al., 2005) 
is not caused by loss of lymphoid potential 
by a homogeneous population of stem 
cells,  but  rather  by  expansion  of  HSC 
populations with predominantly myeloid 
potential  (Beerman  et  al.,  2010).  This 
model is also supported by recent experi-
ments using limiting dilution transplanta-
tion of total bone marrow (Cho et al., 
2008).  Collectively,  these  data  suggest 
that  the  output  of  different  blood  cell 
types by the hematopoietic system may 
be influenced by a balance of coexisting 
stem cell populations with different lin-
eage propensities. The proportions of dif-
ferent stem cells appear to impact the final 
composition of differentiated blood cell 
populations even before the separation of 
distinct lineages occurs (Fig. 1).
CD150
high HSCs reside at the top  
of the HSC hierarchy
If different HSC populations coexist,   
an important question is whether they 
exist in a hierarchy. In principle, the 
Figure 1.  Homogeneous versus heterogeneous HSC populations. (A) Traditional scheme of a 
uniform HSC population in which each cell has a similar propensity to give rise to different lineage-
committed progeny (top). Propensities to generate different lineages are symbolized by different 
colors. The composition of pool of differentiated cells (bottom) is determined by different production 
rates beyond the stem cell level (indicated by thickness of arrows). (B) New findings suggest that the 
propensities of different HSCs to give rise to different lineages are fixed, so the lineage mix in the 
periphery may be influenced by the composition of the HSC pool. Morita et al. (2010) show that dif-
ferent lineage-biased HSCs can be enriched using the surface marker CD150.JEM VOL. 207, June 7, 2010 1129
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the potential to give rise to themselves, 
as well as to all other stem cell popula-
tions after transplantation. Absence or 
low expression of CD150 on HSCs is 
associated with the acquisition of pow-
erful lymphoid reconstitution potential. 
In the future, it will be important to 
further  define  the  precise  regulation, 
developmental relationships, and cross 
talk between different HSC populations, 
as well as to explore their role in disease.
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Limitations of current definitions  
for HSCs
At least in primary transplant recipients, 
“latent” HSCs do not meet widely ac-
cepted  operational  criteria  for  HSC 
activity,  which  set  the  bar  at  a  >1% 
contribution to myeloid and lymphoid 
progeny in the peripheral blood for 16 
wk  (Morrison  and  Weissman,  1994; 
Miller and Eaves, 1997; Ema et al., 
2005).  As  such  cells  are  undoubtedly 
very potent HSCs, Morita et al. (2010) 
reasonably emphasize that current crite-
ria for defining HSCs may need to be 
reexamined. In fact, defining HSC ac-
tivity based on peripheral blood analysis 
alone is also problematic for biological 
reasons. Although granulocytes are short-
lived so that their presence in the blood, 
indeed, indicates ongoing active cell 
production, the situation is much more 
complicated with blood B and T lym-
phocytes. Conditional ablation of B and 
T  cell  production  by  time-controlled 
disruption of the recombination-activating 
gene-2 gene has shown that peripheral   
B and T lymphocytes are maintained 
for very long time periods, even in the 
absence of any new production (Hao 
and Rajewsky, 2001; Bourgeois et al., 
2008). For example, naive follicular B 
cells are only gradually lost, with a half-
life of 4.5 mo, and some smaller B 
cell  subsets  remain  stable  indefinitely 
(Hao and Rajewsky, 2001). As a result, 
using 1% lymphoid reconstitution as a 
criterion may lead to considerable overes-
timates of HSC properties, particularly 
for HSC populations with predominantly 
lymphoid output. Thus, there is reason 
to critically rethink current definitions 
of HSCs.
Conclusion
It is emerging that heterogeneous HSC 
populations in the bone marrow coexist 
and coordinately give rise to hemato-
poiesis.  In  combination  with  other 
markers,  the  SLAM  family  member 
CD150 allows for the prospective en-
richment of HSC populations with dis-
tinct characteristics. High expression of 
CD150 appears to identify cells at the 
very top of the hematopoietic hierar-
chy, as it is correlated with high self- 
renewal and marks the only cells with 
10% of CD150
high HSCs represent “la-
tent” stem cells, which did not give rise 
to detectable progeny for at least 3 mo 
after transplantation, and then produced 
only low levels of myeloid reconstitu-
tion in the primary host. Yet, they gave 
rise to robust, progressive multilineage 
engraftment after secondary transplanta-
tion. The authors speculate that “latent” 
HSCs  may  overlap  with  recently  de-
scribed highly quiescent label-retaining 
HSCs (Wilson et al., 2008; Foudi et al., 
2009). Such label-retaining HSCs, like 
“latent” HSCs, exhibited much stron-
ger  reconstitution  activity  after  sec-
ondary  transplantation  (Wilson  et  al., 
2008; Foudi et al., 2009). Single-cell 
transplantation of label-retaining HSCs 
will be necessary to definitively clarify 
their  overlap  with  “latent”  HSCs. 
Whether or not they are quiescent, the 
existence  of  the  latent  reconstitution 
patterns demonstrates that not all HSCs 
contribute  to  blood  formation  at  all 
times. This observation is reminiscent 
of  retroviral  marking  experiments, 
which suggested that hematopoiesis at 
any given time is sustained by only very 
few  clones  (Lemischka  et  al.,  1986;   
Jordan and Lemischka, 1990). These 
experiments support a clonal succession 
model, in which most of the cells within 
the HSC pool remain quiescent, peri-
odically releasing active clones to sus-
tain blood production, as previously 
active clones exhaust their proliferative 
capacity. However, a clonal succession 
model  was  difficult  to  reconcile  with 
data from chimeric mice made with dif-
ferent  embryonic  stem  cell  founders 
(Harrison et al., 1987) that showed that 
hematopoiesis was sustained simultane-
ously by large numbers of HSCs derived 
from different founder cells. Neverthe-
less, the latter observations do not prove 
that all or even the majority of HSCs 
produce blood at all times. It is tempt-
ing to speculate that latent stem cell be-
havior may be even more common in 
the nontransplanted host in the absence 
of stimulation from cytopenias resulting 
from myeloablative irradiation. It will 
likely be possible in the future to di-
rectly investigate such issues using con-
ditional clonal genetic marking strategies 
that do not involve transplantation.1130 Resolution of diverse HSC subsets | Hock
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